Two Seas Capital LP - Q3 2022 holdings

$110 Million is the total value of Two Seas Capital LP's 12 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 50.0% .

 Value Shares↓ Weighting
HTZZ SellHERTZ GLOBAL HLDGS INC$20,015,000
-41.5%
1,229,426
-43.1%
18.28%
-59.0%
BuyROIVANT SCIENCES LTD$18,900,000
+35.8%
5,869,690
+71.6%
17.26%
-4.7%
RENN BuyRENREN INCsponsored ads$14,892,000
+29.5%
502,925
+26.5%
13.60%
-9.1%
SPY NewSPDR S&P 500 ETF TRput$12,858,00036,000
+100.0%
11.74%
ABUS BuyARBUTUS BIOPHARMA CORP$10,799,000
+13.8%
5,653,917
+61.5%
9.86%
-20.2%
TWTR NewTWITTER INC$10,324,000235,494
+100.0%
9.43%
EFA NewISHARES TRput$9,522,000170,000
+100.0%
8.70%
OMEX BuyODYSSEY MARINE EXPL INC$4,253,000
+1.4%
1,371,874
+11.6%
3.88%
-28.8%
AMBC BuyAMBAC FINL GROUP INC$4,150,000
+36.2%
325,526
+21.3%
3.79%
-4.4%
SONO NewSONOS INC$3,398,000244,438
+100.0%
3.10%
HTZZW SellHERTZ GLOBAL HLDGS INC*w exp 06/30/205$356,000
-11.4%
40,402
-1.5%
0.32%
-37.9%
 ROIVANT SCIENCES LTD*w exp 09/30/202$43,000
-35.8%
111,5090.0%0.04%
-55.2%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
HERTZ GLOBAL HLDGS INC8Q3 202379.6%
ROIVANT SCIENCES LTD8Q3 202352.9%
ARBUTUS BIOPHARMA CORP8Q3 202320.8%
ODYSSEY MARINE EXPL INC8Q3 20235.5%
HERTZ GLOBAL HLDGS INC8Q3 20231.0%
AMBAC FINL GROUP INC7Q2 20234.0%
SONOS INC7Q3 20235.1%
ROIVANT SCIENCES LTD7Q2 20231.3%
RENREN INC4Q3 202215.0%
META PLATFORMS INC4Q3 20237.9%

View Two Seas Capital LP's complete holdings history.

Latest filings
TypeFiled
SC 13D/A2024-03-29
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G2023-11-21
13F-HR2023-11-14
SC 13G2023-10-05
SC 13D2023-10-02
13F-HR2023-08-14

View Two Seas Capital LP's complete filings history.

Compare quarters

Export Two Seas Capital LP's holdings